PG
Procter & GamblePrevious close
161.57
Change
+0.98 / +0.61%
P/E (TTM) ?
23.5
Market Cap
$377B
1M
+11.21%
S&P 500 −0.91% over same period
Volume / Avg Volume
11.7M / 10.2M
1.14× average
Latest earnings analysisFY2027 Q1Reported 2026-10-22
P&G FY2027 Q1: sales up 4.0%, EPS beats, margin squeeze persists
P&G beat the $1.94 consensus EPS by $0.03 and grew sales 4.0%, yet gross margin fell 160 basis points — the quarter was a volume-and-mix win paid for with cost pressure. Read the scorecard for growth, then the margin lines and the $0.79 per-share cost headwind embedded in guidance, which is where the real story sits.
Read the full analysis →Revenue$23.28BYoY +4.00%
EPS (non-GAAP)$2.00Beatest. $1.94
Next-day move−2.76%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2027 Q1 Quarter ended 2026-09 | 2026-10-22 | $23.3B | Read analysis → |
| FY2026 Q4 Quarter ended 2026-06 | 2026-07-29 | $87.0B | Read analysis → |
| FY2026 Q3 Quarter ended 2026-03 | 2026-04-24 | $21.2B | Pending |
| FY2026 Q2 Quarter ended 2025-12 | 2026-01-22 | $22.2B | Pending |
| FY2026 Q1 Quarter ended 2025-09 | 2025-10-24 | $22.4B | Pending |
| FY2025 Q4 Quarter ended 2025-06 | 2025-07-29 | $84.3B | Pending |
| FY2025 Q3 Quarter ended 2025-03 | 2025-04-24 | $19.8B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 35 of its 5-year rangeMid-range
5-year range 21.1 – 29.1 · Median 24.9
Last 4 quarters: $5.0B in buybacks + $10.3B in dividends, 4.06% of market cap combined
P/E (TTM)
23.5
P/B
6.9
P/S
4.3
Dividend Yield
2.49%
Earnings Reaction
Over the last 7 reports, the stock moved ±1.2% on average on the first trading day after, rising 3 times
Most recent −2.76%
Volatility & Correlation
1-year beta -0.09 · Correlation with S&P 500 -0.06Low beta
Annualized volatility 21% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 21 · $15.0MNet selling $15.0M
- 10-23Gama PaulCEO- Health CareSell$0.70M4,331 shares · Avg price 161.27
- 10-23Purushothaman BalajiChief Human Resources OfficerSell$0.67M4,181 shares · Avg price 160.71
- 10-23Jejurikar ShaileshChairman, President and CEOSell$5.7M35,000 shares · Avg price 163.09
- 10-05Whaley Susan StreetChief Legal Officer & SecySell$0.34M2,369 shares · Avg price 145.34
- 10-05Gama PaulCEO- Health CareSell$0.32M2,225 shares · Avg price 145.34
- 10-05Schulten AndreChief Financial OfficerSell$0.57M3,914 shares · Avg price 145.34
- 08-24Janzaruk Matthew W.SVP - Chief Accounting OfficerSell$0.05M359 shares · Avg price 145.24
- 08-21Raman Sundar G.CEO-Fabric Home & Habitat CareSell$0.49M3,435 shares · Avg price 143.02
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2027 Q1 | 23.28 | +4.0% | 49.8% | 4.73 | 1.97 |
| FY2026 Q4 | 21.20 | +1.5% | 48.5% | 3.05 | 1.26 |
| FY2026 Q3 | 21.24 | +7.4% | 49.5% | 3.93 | 1.63 |
| FY2026 Q2 | 22.21 | +1.5% | 51.2% | 4.32 | 1.78 |
| FY2026 Q1 | 22.39 | +3.0% | 51.4% | 4.75 | 1.95 |
| FY2025 Q4 | 20.89 | +1.7% | 49.1% | 3.62 | 1.48 |
| FY2025 Q3 | 19.78 | −2.1% | 51.0% | 3.77 | 1.54 |
| FY2025 Q2 | 21.88 | +2.1% | 52.4% | 4.63 | 1.88 |
| FY2025 Q1 | 21.74 | −0.6% | 52.1% | 3.96 | 1.61 |
| FY2024 Q4 | 20.53 | −0.1% | 49.6% | 3.14 | 1.27 |
| FY2024 Q3 | 20.20 | +0.6% | 51.2% | 3.75 | 1.52 |
| FY2024 Q2 | 21.44 | +3.2% | 52.7% | 3.47 | 1.40 |